According to ViiV Healthcare -- GlaxoSmithKline ( NYSE: GSK ) , Pfizer ( NYSE: PFE ) , and Shionogi 's HIV drug consortium -- one in three Americans fails to take their HIV medication as prescribed. That means hundreds of thousands of patients ... Motley Fool, 3 days ago
Glaxo, Pfizer's ViiV Wins Approval for HIV Combo Drug - Bloomberg, 1 week ago
ViiV says Phase III maraviroc study shows inferior efficacy to emtricitabine/tenofovir - Pharma Letter, 1 month ago
2 images for "Shionogi"
Research and Markets: Global Postmenopausal Vaginal Atrophy Drugs Market 2014-2018 with Actavis, Novo Nordisk, Pfizer & Shionogi & Co. Dominating
The Global PVA Drugs market can be divided into two segments: Topical Estrogen and Systemic Estrogen. To calculate the market size, the report considers the revenue generated from the sales of various drugs (creams, tablets, ...Morningstar.com, 1 month ago Global Postmenopausal Vaginal Atrophy Drugs Market 2014-2018 with Actavis, Novo Nordisk, Pfizer & Shionogi & Co. Dominating Individual.com, 1 month ago Global PVA Drugs market will grow at 7.1% CAGR over the period 2013-2018. TransWorldNews, 2 weeks ago RESEARCH AND MARKETS : Global Postmenopausal Vaginal Atrophy Drugs Market 2014-2018 with Actavis, Novo Nordisk, Pfizer & Shionogi & Co. Dominating 4 Traders, 1 month ago
More from: Stock Nod, Stock Nod...and 29 other sources
|SEC Filings, 1 month ago SHIONOGI & CO LTD (0001281721) SEC, 1 month ago|
|Noodls, 2 hours ago SHIONOGI : Transfers All Assets in Ezose Sciences, a US Subsideary Providing Glycan Analytical Services, to Sumitomo Bakelite Co., Ltd. 4 Traders, 4 weeks ago Shionogi Transfers All Assets in Ezose Sciences, a US Subsideary Providing Glycan Analytical Services, to Sumitomo Bakelite Co., Ltd. Noodls, 4 weeks ago|
Shionogi : ViiV Healthcare Receives FDA approval for Triumeq a Single-pill Regimen Containing the Integrase Inhibitor 'Dolutegravir'
Release date- 25082014 - Osaka, Japan , - Shionogi & Co., Ltd. (Head Office: Osaka ; President & CEO: Isao Teshirogi , Ph.D.; hereafter ' Shionogi ') today announced that the UK -based company, ViiV Healthcare Ltd. (Head Office: London ; Chief ...4 Traders, 4 days ago ViiV Healthcare Receives FDA approval for Triumeq®,a Single-pill Regimen Containing the Integrase Inhibitor Dolutegravir Noodls, 4 days ago Shionogi to Determine the Contents of Stock Options as Compensation (Stock Acquisition Rights) HispanicBusiness.com, 1 month ago Triumeq US Approval Noodls, 3 days ago
Pragma Pharmaceuticals is re-launching Moxatag 775 mg (amoxicillin extended-release tablets). In its release on Aug. 15 , the Company said that Pragma acquired Moxatag from Shionogi in March 2014 and has been working to make the product available ...4 Traders, 1 week ago Fera to roll out Moxatag authorized generic Chain Drug Review, 3 days ago CORRECTING and REPLACING Pragma Pharmaceuticals Announces Re-Launch of Moxatag® Stock Nod, 1 week ago Pragma Pharmaceuticals Releases Moxatag Individual.com, 1 week ago
More from: Reuters, Minyanville...and 36 other sources
StructureActivity Relationship Studies and Discovery of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4-[3-Chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517
† Discovery Research, Purdue Pharma LP, 6 Cedar Brook Drive, Cranbury, New Jersey 08512, United States‡ Shionogi Research Laboratories, Shionogi & Co., Ltd., 3-1-1 Futaba-chow, Toyonaka,Journal of Medicinal Chemistry, 4 weeks ago
By Targeted News Service ALEXANDRIA, Va. , July 17 -- ViiV Healthcare, Research Triangle Park, North Carolina , and Shionogi & Co. , Osaka, Japan , have been assigned a patent (8,778,943) developed by four co-inventors for "substituted ...4 Traders, 1 month ago U.S. Patents Awarded to Inventors in North Carolina (July 17) TMC Net, 1 month ago
Summary The Chinese issues have caused the stock price to fall and we believe this fall has created a buying opportunity. Sales growth for Promacta remains strong and the addition of another indication will allow the company to further grow its ...Seeking Alpha, 8 hours ago
LONDON ( Alliance News ) - Plethora Solutions Holdings PLC Friday said it hopes to raise around GBP15.9 million to fund the USD25 million acquisition of the royalty rights in PSD502 thus consolidating the group's intellectual property rights, as its ...4 Traders, 12 hours ago INTERIM RESULTS TrustNet, 12 hours ago Plethora Solutions Holdings PLC Fundraising and Notice of General.. ADVFN UK, 12 hours ago Fundraising and Notice of General Meeting TrustNet, 13 hours ago
on your WebpageAdd Widget >Get your members hooked!